Description
An antimycobacterial compound; active against drug-sensitive and -resistant clinical isolates of M. tuberculosis (MIC90s = 0.01194-0.01248 and 0.01221-0.01341 μg/ml, respectively); inhibits the synthesis of methoxy- and keto-mycolic acid in the M. bovis strain BCG (IC50s = 0.036 and 0.021 μg/ml, respectively); inhibits the growth of the M. tuberculosis strain H37Rv in infected THP-1 cells at 0.1, 0.3, and 1 μg/ml; decreases lung bacterial burden in a mouse model of M. tuberculosis infection in a dose-dependent manner
Formal name: (2R)-2,3-dihydro-2-methyl-6-nitro-2-[[4-[4-[4-(trifluoromethoxy)phenoxy]-1-piperidinyl]phenoxy]methyl]-imidazo[2,1-b]oxazole
Synonyms: OPC-67683
Molecular weight: 534.5
CAS: 681492-22-8
Purity: ≥98%
Formulation: A crystalline solid